Tanke Biosciences Stock Performance
| TNBI Stock | USD 0.03 0.01 45.00% |
Tanke Biosciences holds a performance score of 10 on a scale of zero to a hundred. The entity has a beta of 4.09, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tanke Biosciences will likely underperform. Use Tanke Biosciences maximum drawdown and the relationship between the semi variance and price action indicator , to analyze future returns on Tanke Biosciences.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tanke Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent fundamental drivers, Tanke Biosciences demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -1.5 M |
Tanke |
Tanke Biosciences Relative Risk vs. Return Landscape
If you would invest 1.00 in Tanke Biosciences on September 25, 2024 and sell it today you would earn a total of 1.90 from holding Tanke Biosciences or generate 190.0% return on investment over 90 days. Tanke Biosciences is currently generating 7.2396% in daily expected returns and assumes 53.8723% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Tanke, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tanke Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tanke Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Tanke Biosciences, and traders can use it to determine the average amount a Tanke Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1344
| Best Portfolio | Best Equity | TNBI | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 53.87 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Tanke Biosciences is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tanke Biosciences by adding it to a well-diversified portfolio.
Tanke Biosciences Fundamentals Growth
Tanke Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Tanke Biosciences, and Tanke Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tanke Pink Sheet performance.
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0012 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0) % | |||
| Current Valuation | 4.56 M | |||
| Shares Outstanding | 13.32 M | |||
| Price To Earning | (0.08) X | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 0.09 X | |||
| Revenue | 28.56 M | |||
| EBITDA | 804.29 K | |||
| Cash And Equivalents | 5.09 M | |||
| Cash Per Share | 0.38 X | |||
| Debt To Equity | 0.60 % | |||
| Book Value Per Share | 1.17 X | |||
| Cash Flow From Operations | (1.18 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 28.85 M | |||
| Retained Earnings | 1.62 M | |||
| Current Asset | 19.7 M | |||
| Current Liabilities | 12.23 M | |||
About Tanke Biosciences Performance
By evaluating Tanke Biosciences' fundamental ratios, stakeholders can gain valuable insights into Tanke Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tanke Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tanke Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. TANKE BIOSCIENCES operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 130 people.Things to note about Tanke Biosciences performance evaluation
Checking the ongoing alerts about Tanke Biosciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Tanke Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tanke Biosciences is way too risky over 90 days horizon | |
| Tanke Biosciences has some characteristics of a very speculative penny stock | |
| Tanke Biosciences appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 28.56 M. Net Loss for the year was (210.25 K) with profit before overhead, payroll, taxes, and interest of 9.94 M. | |
| Tanke Biosciences currently holds about 5.09 M in cash with (1.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Tanke Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tanke Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Tanke Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tanke Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tanke Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tanke Biosciences' pink sheet. These opinions can provide insight into Tanke Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Tanke Pink Sheet analysis
When running Tanke Biosciences' price analysis, check to measure Tanke Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanke Biosciences is operating at the current time. Most of Tanke Biosciences' value examination focuses on studying past and present price action to predict the probability of Tanke Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanke Biosciences' price. Additionally, you may evaluate how the addition of Tanke Biosciences to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |